Integrated translational research models reshape early drug development strategies
Continuous compliance becomes critical for CRDMOs
The Future of Clinical Research in India: Can India Become a Global Trial Hub?
The ADC Opportunity Is Expanding – So Are the Demands on Development Partners
CRDMOs Transform Early Drug Development with Seamless Integration of Translational & Clinical Research
How India is Becoming the Next Clinical Research Destination
Advancing Innovation in a New Era of Drug Development
Syngene at CPHI Frankfurt
Syngene International Closes 2025 with Firm Foundation in Baltimore, Looks Ahead to a Strong 2026
From curiosity to careers: How early STEM engagement shapes aspirations in underserved communities
